Plunkett Research Online: Galectin Therapeutics Inc

GALECTIN THERAPEUTICS INC (GALT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Drug research and development company.....

Galectin Therapeutics Inc
Ticker: GALT
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 678 620-3186
Fax: 770 864-1327
Address: 4960 Peachtree Industrial Boulevard
Suite 240
Norcross, GA 30071 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Jack Callicutt CFO/Chief Accounting Officer/Secretary
Richard Uihlein Chairman of the Board/Director
See More
Drug research and development company.....See More See More

Auditor: Cherry Bekaert LLP
Legal Advisor: McCarter & English, LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: